cerrar
Tagged with USA,

Bill Sibold – Executive Vice President, Sanofi Genzyme
Speaking exclusively to PharmaBoardroom, Sanofi Genzyme Executive VP Bill Sibold outlines Sanofi’s strategy for its specialty care unit, the wealth…

Can We Afford to Pay for Future Cures?
Pharmaceutical innovation is racing ahead of the US health system's ability to adjust payment models, but innovative concepts are finally emerging. We…

LFB USA CEO Optimistic on Hemophilia Launches Amid COVID Crisis
French firm LFB is targeting the lucrative US market with its hemophilia products and recently received two FDA approvals. Although launching new…

Accumulating Barriers to Care: Double Jeopardy for US Patients
Dan Leonard, Kimberly Westrich, and Brian Sils of the National Pharmaceutical Council examine how a new HHS ruling on how US patients pay for…

Brett Monia – CEO, Ionis Pharmaceuticals
Dr Brett Monia, co-founder and CEO of RNA therapeutics pioneer Ionis Pharmaceuticals, outlines the company’s extremely promising development…

Christopher Posner – EVP of Region US, LEO Pharma A/S;…
Christopher Posner, US head for Danish medical dermatology specialist LEO Pharma, outlines how a mid-sized European company navigates the US market's…

US Generics: Company Culture Key to Attracting Talent
Two leading executives in the US generics market outline why robust company culture is key to attracting top talent that might otherwise gravitate…

The FDA’s COVID-19 Shakeup
In a recent virtual town hall meeting hosted by BIO, two key leaders from the US FDA laid out how their organisation has adjusted in the wake of the…

BIO 2020: How COVID-19 Will Radically Alter Global Biomedical…
The BIO International Convention was held digitally in June 2020, bringing together over 7,000 participants from around the world. In an…

Menarini Makes Big US Oncology Move with Stemline Acquisition
Menarini Group, the largest Italian pharmaceutical company by turnover, has made its first move into the US oncology market through the acquisition of…

COVID-19: 95% of US Rare Disease Patients Affected
As of 11 June 2020, there have been over two million confirmed cases of COVID-19 in the US and over 115,000 deaths, with the US having occupied the…

Peter L. Saltonstall – President & CEO, National…
Peter L Saltonstall, president and CEO of the US National Organization for Rare Disorders (NORD) shares the organization’s key priorities, what…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here